Free Trial
→ Trump doesn’t give a damn (From Porter & Company) (Ad) Free BDRX Stock Alerts

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$3.71 -0.09 (-2.37%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$3.64 -0.08 (-2.02%)
As of 02/21/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Biodexa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/18/2025
3:30 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Shocking Elon Move: Bigger than DOGE? (Ad)

After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recent DOGE moves… What Elon Musk is about to do next could not only shock the world… But also put an extra $30,000 a year in your pocket.

Click here to see the details BEFORE March 17th…
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/12/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM		Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM		Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
8:34 AM		Biodexa Pharmaceuticals (Filer)
Form 424B5
07/19/2024
12:00 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K/A
07/19/2024
8:03 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/05/2024
4:24 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
7:44 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Trump doesn’t give a damn (Ad)

Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…

Go here now to find out the names of these 10 stocks.
06/24/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/17/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2024
8:48 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/29/2024
8:04 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BDRX) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Warning: China Launches AI Attack on America
If you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...
InvestorPlace | Sponsored
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...
Timothy Sykes | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored